Effect of priming in preventing myoclonic movements after intravenous induction with etomidate in adult patients undergoing cardiac surgery: a randomised controlled interventional study
Etomidate is a hypnotic drug used as an intravenous anaesthetic induction agent. Etomidate causes myoclonic movements in 50-80% patients after induction which makes it less desirable for induction. Aim: Present study was to determine the effect of priming in preventing myoclonic movements after intr...
Saved in:
Main Authors: | Mukesh K Sunda (Author), Kanchan Chauhan (Author), Rajeev Kumar Prajapati (Author), Krishna Boliwal (Author) |
---|---|
Format: | Book |
Published: |
Creative Pharma Assent,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparison of midazolam and dexmedetomidine for the prevention of myoclonic movements and pain following etomidate injection
by: Sema Aktolga, et al.
Published: (2010) -
Comparative study evaluating efficacy of sufentanil versus midazolam in preventing myoclonic movements following etomidate
by: Mohammad Alipour, et al.
Published: (2016) -
Optimization, and in vitro and in vivo evaluation of etomidate intravenous lipid emulsion
by: Dandan Geng, et al.
Published: (2021) -
Comparison of Remimazolam Tosilate and Etomidate on Hemodynamics in Cardiac Surgery: A Randomised Controlled Trial
by: Hu B, et al.
Published: (2023) -
Treatment of myoclonic encephalopathy of childhood (Kinsbourne sydrome) with methotrexate and intravenous
by: Torres Mayagoita Dessiré, et al.
Published: (2014)